These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25299875)

  • 1. Changes in QT intervals after azithromycin-containing antibiotic therapy in patients with NTM lung disease.
    Shin B; Park HY; Koh WJ
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1385. PubMed ID: 25299875
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium malmoense as an extrapulmonary pathogen of cats.
    Hetzel U; Dixon CE; Just AE; Birtles RJ; Kipar A
    Vet Rec; 2012 Sep; 171(11):274. PubMed ID: 22865116
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacterium nebraskense as a cause of nodular pulmonary disease.
    Puthalapattu S; Metersky ML
    Conn Med; 2011 Oct; 75(9):527-9. PubMed ID: 22308639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases.
    Tsuji T; Tsuyuguchi K; Tachibana K; Kimura Y; Kobayashi T; Minomo S; Atagi S; Matsumura A; Hayashi S; Suzuki K
    Respir Investig; 2017 Jan; 55(1):45-50. PubMed ID: 28012493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium marinum cutaneous infection with sporotrichoid distribution treated with azithromycin monotherapy.
    Rallis E; Falidas E; Stavropoulos P
    Skinmed; 2012; 10(1):54-5. PubMed ID: 22324181
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.
    Catherinot E; Roux AL; Vibet MA; Bellis G; Lemonnier L; Le Roux E; Bernède-Bauduin C; Le Bourgeois M; Herrmann JL; Guillemot D; Gaillard JL;
    Eur Respir J; 2013 May; 41(5):1101-6. PubMed ID: 22936714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.
    Winthrop KL; Ku JH; Marras TK; Griffith DE; Daley CL; Olivier KN; Aksamit TR; Varley CD; Mackey K; Prevots DR
    Eur Respir J; 2015 Apr; 45(4):1177-9. PubMed ID: 25614169
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifabutin-associated uveitis in an immunocompetent individual with Mycobacterium simiae.
    Jetton J; Gaviria JG; Patterson TF; Johnson DA
    Can J Ophthalmol; 2009 Aug; 44(4):468-9. PubMed ID: 19606179
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and treatment of nontuberculous Mycobacterium sinusitis.
    Suh JD; Ramakrishnan VR; Tajudeen B; Reger C; Kennedy DW; Chiu AG
    Am J Rhinol Allergy; 2011; 25(6):421-4. PubMed ID: 22185748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Mycobacterium gordonae infection in a child with cystic fibrosis.
    Verma N; Spencer D
    Pediatr Pulmonol; 2012 May; 47(5):517-8. PubMed ID: 22028301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
    Hwang SM; Lim MS; Hong YJ; Kim TS; Park KU; Song J; Lee JH; Kim EC
    Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin associated with a small increased risk of cardiovascular death: a review.
    Wynn RL
    Gen Dent; 2013; 61(2):8-9. PubMed ID: 23454312
    [No Abstract]   [Full Text] [Related]  

  • 20. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.